Predict your next investment

Non-Profit Foundation
pirbright.co.uk

See what CB Insights has to offer

Partners & Customers

7

About Pirbright Institute

The Pirbright Institute is a research institute in Surrey, England, dedicated to the study of infectious diseases of farm animals.

Pirbright Institute Headquarter Location

Ash Road Pirbright

Surrey, England, GU24 0NF,

United Kingdom

+44 (0)1483 232441

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Pirbright Institute News

£40 million UK animal vaccine centre to be established at Pirbright

Jun 14, 2021

The Plowright Building at Pirbright. James Brittain, HDR Architecture A new £40 million centre at Pirbright to develop vaccines for zoonotic diseases that spread from animals to humans is to be established as part of a landmark global health declaration by G7 leaders. It was part of a commitment made by leaders at the G7 meeting in Carbis Bay, Cornwall, to ensure that the global devastation caused by Covid-19 is never repeated. The new UK Animal Vaccine Manufacturing and Innovation Centre will be established at the Pirbright Institute campus in Surrey. The centre will be funded by Foreign Commonwealth and Development Office, Biotechnology and Biological Sciences Research Council (BBSRC) and the Bill & Melinda Gates Foundation (BMGF). The UK government will contribute £18.5 million while The Bill & Melinda Gates Foundation will provide £14.5 million to establish the centre, building on its current investments in vaccines for livestock and zoonotic diseases at The Pirbright Institute. Accelerating vaccines for livestock diseases The new centre will draw on Pirbright’s expertise to accelerate the delivery of vaccines for livestock diseases. Three in every four new human diseases originate in animals and these diseases are emerging at an increasing rate. Controlling zoonotic diseases is a key element of the UK Government’s five-point plan for preventing future pandemics – the first plan articulated by a G7 leader on pandemic preparedness. Part of this plan is to establish a UK Animal Vaccine Manufacturing and Innovation Centre at Pirbright with the aim of stopping new animal-borne diseases before they put people at risk. The Carbis Bay declaration will set out the steps G7 countries will take to prevent a future pandemic, including slashing the time taken to develop and licence vaccines, treatments and diagnostics for any future disease to under 100 days, a commitment to reinforce global surveillance networks and genomic sequencing capacity and support for reforming and strengthening the World Health Organisation. Zoonotic diseases pose a risk to people if they mutate to become transmissible to humans and can devastate agriculture in the UK and internationally. Often the risks and complexities associated with early-stage vaccine research mean that the field struggles to get private investment. The centre will rapidly assess promising new technologies in the field, and develop and test novel vaccines for emerging diseases. Two devastating global diseases – smallpox and rinderpest (the first two diseases in history to be totally wiped out) were eradicated using vaccines developed by British scientists, the latter included Pirbright scientist Walter Plowright. Advertisement UK Prime Minister Boris Johnson said: “In the last year the world has developed several effective coronavirus vaccines, licenced and manufactured them at pace and is now getting them into the arms of the people who need them. “But to truly defeat coronavirus and recover we need to prevent a pandemic like this from ever happening again. That means learning lessons from the last 18 months and doing it differently next time around. “I am proud that for the first time today the world’s leading democracies have come together to make sure that never again will we be caught unawares.” Pirbright director and chief executive Prof. Bryan Charleston said: “There is a global unmet need to accelerate the development of vaccines from the laboratory to provide effective products for livestock keepers to control disease in their animals. “Preventing disease by vaccination will help secure food supplies and so improve human health and welfare.” Stronger global disease surveillance Dr. Tedros Adhanom, director-general of the World Health Organisation (WHO), said: “Together we need to build on the significant scientific and collaborative response to the Covid-19 pandemic and find common solutions to address many of the gaps identified. “To this end, WHO welcomes and will take forward the UK’s proposal for a Global Pandemic Radar. As we discussed, the world needs a stronger global surveillance system to detect new epidemic and pandemic risks.” Prof. Melanie Welham, BBSRC executive chief, added: “In the last year, more than ever, we have recognised the global importance of vaccine research and how the UK plays a leading role. Now, we can take the opportunity of joining UK expertise with an international effort in the field of veterinary vaccines. “The new facility – which BBSRC will co-fund – at the world-renowned Pirbright Institute, will be a shield and a sword against animal diseases that can devastate agriculture and infect human populations.” Initial vaccine development work will take place at the Plowright Building (pictured top), Pirbright’s state-of-the-art high containment research facility before being assessed in the new Animal Vaccine Innovation Centre. The Plowright Building was named after Walter Plowright, who developed a highly successful rinderpest vaccine that contributed to the eradication of the disease.

Pirbright Institute Partners & Customers

7 Partners and customers

Pirbright Institute has 7 strategic partners and customers. Pirbright Institute recently partnered with ECO Animal Health on October 10, 2020.

Date

Type

Business Partner

Country

News Snippet

Sources

10/15/2020

Partner

ECO Animal Health

United Kingdom

Pirbright partners with ECO Animal Health and The Vaccine Group to develop new PRRS vaccines

Pirbright Institute partners with ECO Animal Health and The Vaccine Group to develop new PRRS vaccines .

2

11/21/2019

Partner

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

9/11/2019

Partner

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

5/29/2019

Partner

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

4/12/2018

Partner

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

Date

10/15/2020

11/21/2019

9/11/2019

5/29/2019

4/12/2018

Type

Partner

Partner

Partner

Partner

Partner

Business Partner

ECO Animal Health

Country

United Kingdom

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

News Snippet

Pirbright partners with ECO Animal Health and The Vaccine Group to develop new PRRS vaccines

Pirbright Institute partners with ECO Animal Health and The Vaccine Group to develop new PRRS vaccines .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

2

10

10

10

10

Pirbright Institute Team

1 Team Member

Pirbright Institute has 1 team member, including former Owner, David Gillies.

Name

Work History

Title

Status

David Gillies

Owner

Former

Name

David Gillies

Work History

Title

Owner

Status

Former

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.